Brand Name(s): Ceptaz; Fortaz; Tazicef; Tazidime
CAS nš: 72558-82-8
(sef-tay-zi-deem)
About Ceftazidime
This new site is dedicated exclusively to ceftazidime.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about ceftazidime on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total ceftazidime experience!
Why is this medication prescribed?
Ceftazidime belongs to a group of antibiotics called the cephalosporins. They kill bacteria by interfering with the ability of bacteria to form cell walls. The bacteria therefore break up and die. This medication is given by injection or infusion and is generally used for severe infections.
This particular medicine is used to treat abdominal infections, infections caused by the bacterium, pseudomonas aeruginosa, infections of the organs associated with breathing including the nose, windpipe and lungs (respiratory tract), and infections of the urinary system.
Latest News
Assay determines activity of ceftazidime+tobramycin against
An assay was developed to determine the activity of ceftazidime in combination with tobramycin...
[more]Laboratory detection of bacteria with extended-spectrum beta-lactamases
Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated enzymes that hydrolyse and confer...
[more]American Pharmaceutical Partners Acquires Canadian Market Rights to Five Injectable Products From Eli Lilly Canada Inc.
Schaumburg, Ill. - American Pharmaceutical Partners, Inc. (Nasdaq: APPX), today announced that it...
[more]Penicillin, Cephalosporin Allergy Seldom Confirmed
Chicago -- Skin testing is essential before considering antibiotic substitution in patients who...
[more]